FDA Orange Book
Is there a generic for Aphexda?
Aphexda contains motixafortide acetate. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Aphexda (motixafortide acetate). The Orange Book shows its last listed patent expires December 29, 2041 and its last listed exclusivity ends September 8, 2030.
Run it in Rivvi
Map Aphexda and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Aphexda products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| powder, subcutaneous | EQ 62MG BASE/VIAL | Marketed (Rx) | None | 0 | None |
NDA 217159, held by AYRMID PHARMA LTD. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Aphexda patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 12257285 | December 29, 2041 | Drug product | None | 217159 |
| 12268725 | December 29, 2041 | Drug product | None | 217159 |
Aphexda exclusivity
| Code | Meaning | Expires | NDA |
|---|---|---|---|
| NCE | New chemical entity | September 8, 2028 | 217159 |
| ODE-442 | Orphan drug exclusivity | September 8, 2030 | 217159 |
Aphexda NDC codes
Questions
Is there a generic for Aphexda?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Aphexda (motixafortide acetate). The Orange Book shows its last listed patent expires December 29, 2041 and its last listed exclusivity ends September 8, 2030.
What is the generic name for Aphexda?
The active ingredient in Aphexda is motixafortide acetate, per the FDA Orange Book.
When does the Aphexda patent expire?
The last patent listed for Aphexda in the Orange Book expires December 29, 2041. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.